[1] |
Anastasiadi Z, Lianos GD, Ignatiadou E, et al. Breast cancer in young women: an overview[J]. Updates Surg, 2017,69(3):313-317.
|
[2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
|
[3] |
Burstein HJ, Curigliano G, Loibl S, et al.Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen international consensus guidelines for the primary therapy of early breast cancer 2019 [J]. Ann Oncol, 2019,30(10):1541-1557.
|
[4] |
EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials[J]. Lancet,2014,383(9935):2127-2135.
|
[5] |
Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007[J]. Ann Oncol,2007,18(7):1133-1144.
|
[6] |
Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(4):448-475.
|
[7] |
Senkus E, Kyriakides S, Ohno S,et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2015,26 Suppl 5:v8-30.
|
[8] |
Cao L, G Adedjouma N, Xu C, et al.The role of post-mastectomy radiotherapy in elderly patients with 1-3 positive lymph nodes breast cancer: an international retrospective double-center study [J]. Breast J, 2019,25(1):107-111.
|
[9] |
Chen M, Huang Y, Leng Z, et al. Post-mastectomy radiotherapy in T1-2 breast cancer patients with one to three lymph node metastases: a propensity score matching analysis[J]. Front Oncol,2020,9:1551.
|
[10] |
Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature,2000,406(6797):747-752.
|
[11] |
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet,2011,378(9804):1707-1716.
|
[12] |
World Health Organization.International classification of diseases for oncology[J]. 3th ed.Geneva: WHO, 2013: 218.
|
[13] |
Moran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer[J]. Lancet Oncol,2015,16(3):e113-122.
|
[14] |
Gradishar WJ, Anderson BO, Abraham J, et al. Breast cancer,version 3.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2020,18(4):452-478.
|
[15] |
Gradishar WJ, Anderson BO, Balassanian R, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw,2016,14(3):324-354.
|
[16] |
Wang X, Xu Y, Guo S, et al. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy[J]. Oncol Lett,2020,19(1):735-744.
|
[17] |
Guillaume E, Daguenet E, Lahmamssi C, et al. Predictors of asthenia in breast and prostate cancer patients undergoing curative radiotherapy [J]. Cancer Radiother,2020,24(1):15-20.
|
[18] |
Poortmans PM, Collette S, Kirkove C, et al.Internal mammary and medial supraclavicular irradiation in breast cancer [J]. N Engl J Med,2015,373(4):317-327.
|
[19] |
Wang J, Luo J, Jin K, et al. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients[J]. Cancer Med,2020,9(7):2427-2434.
|
[20] |
Whelan TJ, Olivotto IA, Parulekar WR, et al.Regional nodal irradiation in early-stage breast cancer [J]. N Engl J Med,2015,373(4):307-316.
|
[21] |
Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource[J]. Cancer Epidemiol Biomarkers Prev,1999,8(12):1117-1121.
|
[22] |
Sjöström M, Lundstedt D, Hartman L, et al.Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish breast cancer group 91 radiotherapy randomized clinical trial [J]. J Clin Oncol,2017,35(28):3222-3229.
|
[23] |
Nordenskjöld AE, Fohlin H, Albertsson P, et al. No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study[J]. Ann Oncol,2015,26(6):1149-1154.
|
[24] |
Recht A, Edge SB, Solin LJ, et al.Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology [J]. J Clin Oncol,2001,19(5):1539-1569.
|
[25] |
Shi W, Luo Y, Zhao D, et al. Evaluation of the benefit of post-mastectomy radiotherapy in patients with early-stage breast cancer: A propensity score matching study[J]. Oncol Lett,2019,17(6):4851-4858.
|
[26] |
Wang X, Qi Y, Kong X, et al. Immunological therapy: A novel thriving area for triple-negative breast cancer treatment[J]. Cancer Lett,2019,442:409-428.
|
[27] |
Yu T, Di G. Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance[J]. Chin J Cancer Res,2017,29(3):237-252.
|